Back to results
CompletedPhase 2Phase 3

Caffeine for Excessive Daytime Somnolence in Parkinson's Disease

NCT00459420

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Toronto Western Hospital

Toronto, Ontario, Canada

+1 additional location

View on ClinicalTrials.gov
Caffeine for Excessive Daytime Somnolence in Parkinson's Disease — TrialFind